Home › Namocell, MGH Collaborate on Circulating Tumor Cell Research

Namocell, MGH Collaborate on Circulating Tumor Cell Research

Dec 16, 2016

NEW YORK (GenomeWeb) – Namocell, a developer of microfluidic-based single-cell sorting and capturing platforms, has announced a collaboration with researchers at Massachusetts General Hospital to research circulating tumor cells.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS Approaches for Microbiome Studies

Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

What's Popular?

In Cancer

  1. Colon Cancer Test Distribution Deals Inked by HalioDx

  2. Cancer Genetics Cancels Planned Merger With NovellusDx

  3. Black Women With Breast Cancer Fare Worse, TAILORx Analysis Confirms at SABCS

    Premium

  4. Guardant Health to Develop Blood-Based CDx for AstraZeneca Drugs

  5. Synlab Pharma, Biotype Collaborate on Gastrointestinal, Endometrial Cancers

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.